Apr 22, 2016 by Brian FeroldiWhy Sarepta Therapeutics Inc. Is Bouncing Back TodayInvestors are bidding up shares after the FDA released its list of questions that will be used during next week's advisory committee meeting.
Apr 21, 2016 by Brian FeroldiIs TransEnterix Inc a "Bad News Buy"?Shares collapsed after the FDA rejected its submission for its SurgiBot System. Does the sell-off represent a buying opportunity?
Apr 21, 2016 by Brian FeroldiWhy TransEnterix Inc's Stock Is Being Obliterated TodayBummer news from the FDA sends shares into a tailspin.
Apr 20, 2016 by Brian Feroldi FormFactor Inc. Braces for an Ugly QuarterIt's going to be a rough quarter for the semiconductor probe card manufacturer. Here's a review of what investors can expect.
Apr 20, 2016 by Brian Feroldi, Selena Maranjian, Sean Williams, Dan Caplinger, Chuck Saletta, Matt Frankel, CFP, and Cory Renauer7 Non-Traditional Ways You Can Earn More MoneyLooking for a way to bring a few extra dollars into your life? Our team of contributors think you might want to consider giving these seven methods a try.
Apr 19, 2016 by Brian Feroldi, Keith Speights, and Cory Renauer3 Healthcare Stocks We Won't BuyOur team of healthcare contributors think that these healthcare stocks should be avoided at all costs.
Apr 18, 2016 by Brian Feroldi, Sean Williams, Dan Caplinger, Evan Niu, CFA, and Tyler Crowe5 Top Stocks for Retirees to BuyOur contributors think these five stocks are great choices for investors in their golden years.
Apr 16, 2016 by Brian FeroldiThis Healthcare ETF Was Last Week's Top PerformerHealthcare-focused investors had a solid week, but shareholders of this one ETF did the best.
Apr 14, 2016 by Brian Feroldi, Selena Maranjian, and Dan Caplinger3 Ways to Lose Everything in the Stock MarketLearn more about these minefields so you can tread carefully around them.
Apr 14, 2016 by Brian FeroldiBetter Buy: MannKind Corporation vs. SanofiBoth have been disappointing long-term investments, but which of these two healthcare companies should investors favor today?
Apr 12, 2016 by Brian Feroldi, Keith Speights, and Cory Renauer3 Biotech Stocks to Buy in AprilOn the hunt for a good biotech stock to buy in April? Our Motley Fool healthcare contributors think these three biotech stocks are solid choices.
Apr 11, 2016 by Brian FeroldiMannKind Corporation Is Skyrocketing Today, and Here's WhyShares jump in response to the announcement of a special investor call.
Apr 10, 2016 by Brian Feroldi3 Charts That Explain Acadia Pharmaceuticals Inc StockThese three charts say it all.
Apr 9, 2016 by Brian FeroldiWhy Sarepta Therapeutics Inc. Soared 44% Higher in MarchNews of a new date for an advisory committee meeting has put traders in a good mood.
Apr 8, 2016 by Brian FeroldiHere's Why Nektar Therapeutics Inc. Rose 19% in MarchBetter-than-expected earnings coupled with a catalyst-filled year send shares in the right direction.
Apr 8, 2016 by Brian FeroldiWhy ACADIA Pharmaceuticals Inc Skyrocketed 46% Higher in MarchWhen your lead compound gets the thumbs up from a panel of experts, good things tend to happen.
Apr 7, 2016 by Brian FeroldiOpko Health Rose 11% in March, and Here's WhyEven disappointing news from the FDA couldn't hold back shares from rallying this month.
Apr 7, 2016 by Brian FeroldiMerrimack Pharmaceuticals Inc Rose 28% in March. Here's Why.Shares bounce back from a rough start to the year.
Apr 7, 2016 by Brian FeroldiWhy Ophthotech Corp. Plunged 42% in MarchInvestors may have been reading too much into a couple of C-suiters' tax-season moves.
